Healthcare M&A looks set to be strong again this year, following deals from Shire and Roche. But Goldman Sachs says energy's a sector to watch too.» Read More
Daniel Loeb's Third Point added 1 million shares of Dollar General, raising his stake by 33 percent, while Blue Ridge Capital, founded by Tiger Cub John Griffin, nearly doubled its stake in Walgreen when it bought 2.8 million shares.
BOSTON, Aug 13- Harvard Management Co, which oversees the Ivy League school's $32.7 billion endowment, took a new position in surgical device maker Covidien Plc during the second quarter before news of a planned takeover helped push the stock price higher, a regulatory filing shows.
NEW YORK, Aug 13- Biotechnology company InterMune Inc is working with financial advisers to evaluate strategic options as it braces for potential takeover interest from larger drugmakers, people familiar with the matter said.
The M&A wave could be a harbinger of a booming economy...or a collection of last-minute attempts to beat higher debt rates. NYT reports.
There's been "nothing, nothing, nothing, nothing" from Obama on corporate tax cuts in five years, Grover Norquist tells CNBC.
President Barack Obama’s push to deter U.S. firms from buying foreign companies for tax purposes will make several deals less attractive.
Even as traders monitor the world's hot spots, corporate earnings news could be a positive for stocks in the week ahead.
Walgreen's chief, who said he was "proud of our Illinois heritage," is considering a deal that would move its HQ to Switzerland in a bid to cut taxes.
Investor support for large acquisitions and a desire to trump rivals in consolidating markets have led CEOs to strike big transactions in 2014.
If Bob Olstein is right, the climate for takeovers is just beginning to heat up.
CNBC's David Faber and Jim Cramer dig into upgrades for Medtronic from multiple analysts after the company announced it was buying Covidien.
If anyone hates high taxes, it’s Jim Cramer. And he’s always looking for new ways to do something about them.
U.S. stocks wavered on Monday on strife in Iraq.
Shire has hired investment bank Citi as an adviser following a wave of deals in the healthcare sector.
Some of Monday's midday movers:
Medtronic announced it will buy Covidien for $42.9 billion. Barbara Ryan of FTI Consulting, discusses consolidation in the medical industry.
CNBC's Meg Tirrell provides insight to Medtronic's announcement it will buy Covidien, and also discusses the consolidation trends in medical device companies.
Medtronic's $43 billion Covidien deal may signal future medical-device company mergers.
Medtronic is buying Covidien in a $42.9 billion agreement that could increase concerns about the rush of U.S. companies striking deals to cut their tax bills.
Bill George, Harvard business professor and former Medtronic CEO, shares his thoughts on Medtronic's $43 billion deal to buy the medical device maker for $93.22 per share.